Patents by Inventor Weisheng Liang

Weisheng Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139348
    Abstract: Disclosed are a multi-modality molecular imaging probe, and a preparation method and use thereof. The multi-modality molecular imaging probe has an ABA structure, with a magnetic functional unit of a gadolinium complex at the center, and two identical phosphorescent functional units of an iridium complex, which are reasonably integrated into the same one complex molecule. The multi-modality molecular imaging probe simultaneously introduces two optical functional units of the iridium complex and one magnetic functional unit of a gadolinium chelate in the same one complex molecule, which exhibits magnetic-optical dual functional properties. It therefore could be used to prepare both a contrast agent for magnetic resonance imaging and an optical probe for optical imaging.
    Type: Application
    Filed: September 12, 2023
    Publication date: May 2, 2024
    Inventors: Jiaxi Ru, Xiaoliang Tang, Xiufeng Huang, Weisheng Liu, Chao Liang, Lingling Kang, Xiaofen Chen, Xian Shen
  • Patent number: 5808021
    Abstract: Methods of making and using, as prophylactics or therapeutics for preventing or treating certain diseases including cancer, O-desulfated heparin compositions, preferably 2-O, 3-O desulfated heparin compositions, wherein the methods permit regulating the degree of 2-O, 3-O desulfation to produce compositions that are variably desulfated upto about 99% and 75% desulfated at the 2-O and 3-O positions, respectively.
    Type: Grant
    Filed: April 10, 1997
    Date of Patent: September 15, 1998
    Assignee: Glycomed Incorporated
    Inventors: Kevin R. Holme, Weisheng Liang, David J. Tyrrell, Patrick N. Shaklee
  • Patent number: 5696100
    Abstract: Methods of making and using, as prophylactics or therapeutics for preventing or treating certain diseases including cancer, O-desulfated heparin compositions, preferably 2-O, 3-O desulfated heparin compositions, wherein the methods permit regulating the degree of 2-O, 3-O desulfation to produce compositions that are variably desulfated upto about and 75% desulfated at the 2-O and 3-O positions, respectively.
    Type: Grant
    Filed: February 6, 1995
    Date of Patent: December 9, 1997
    Assignee: Glycomed Incorporated
    Inventors: Kevin R. Holme, Weisheng Liang, Patrick N. Shaklee
  • Patent number: D1017209
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: March 12, 2024
    Inventor: Weisheng Liang